Correction: “Increasing dopamine synthesis capacity in the dorsal striatum and tonic acetylcholine: implications for the new muscarinic agents in the treatment of schizophrenia”

Correction to: Molecular Psychiatry https://doi.org/10.1038/s41380-026-03758-2, published online 09 July 2026 In this article, the author’s name was incorrectly published as James Kesby. The correct author name is James P. The original article has been corrected.

Queensland Centre for Mental Health Research, Wacol, Brisbane, QLD, 4076, Australia Darryl Eyles, Xiaoying Cui & James P. Kesby Queensland Brain Institute, University of Queensland, Brisbane, QLD, 4072, Australia Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA, 94720, USA Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material.

If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Eyles, D., Du, Z., Cui, X. et al.

Correction: “Increasing dopamine synthesis capacity in the dorsal striatum and tonic acetylcholine: implications for the new muscarinic agents in the treatment of schizophrenia”. Mol Psychiatry (2026). https://doi.org/10.1038/s41380-026-03923-7 DOI: https://doi.org/10.1038/s41380-026-03923-7